Fundraise led by Sofinnova Partners, F-Prime Capital, Digitalis Ventures and Cambridge Innovation Capital with participation from Sanofi Ventures and the University of Cambridge Venture Fund Unique transgenic mouse platform harnesses natural power of T cells Read More
Tags :F-Prime Capital
CHARM Therapeutics is applying its end-to-end 3D deep learning protein-ligand co-folding technology, DragonFold, to develop small molecule therapeutics against previously hard-to-drug&Read More
OTA Insight Raises $80M Series B Funding from Spectrum Equity to Bring Data-Driven Decisions to Hospitality Industry London, Denver & Singapore – OTA Insight, the global leader in cloud-based hospitality business intelligence, has raised $80 million Read More